Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Atlas Arteria ( (AU:ALX) ) has provided an update.
Atlas Arteria reported a 10.7% increase in toll revenue for Q2 2025, driven by strong traffic performance and favorable foreign exchange rates. The APRR and Dulles Greenway showed notable traffic growth, while the A79 continued its robust performance. The French government’s support for the concession model, with proposed refinements, underscores the importance of tolls in financing infrastructure, potentially impacting future operations and stakeholder interests.
The most recent analyst rating on (AU:ALX) stock is a Hold with a A$5.55 price target. To see the full list of analyst forecasts on Atlas Arteria stock, see the AU:ALX Stock Forecast page.
More about Atlas Arteria
Atlas Arteria is a company operating in the infrastructure industry, primarily focusing on toll road operations. It manages a portfolio of toll roads across various regions, with a significant presence in France and the United States. The company is involved in the operation and management of toll roads, providing essential transport infrastructure services.
Average Trading Volume: 2,084,270
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$7.52B
For a thorough assessment of ALX stock, go to TipRanks’ Stock Analysis page.

